Referring to drugs and medications, the term encompasses the entire process of drug development, manufacturing, distribution, and use for therapeutic or diagnostic purposes.
The step-by-step process of discovering, testing, and bringing a new pharmaceutical product to the market, involving preclinical studies, clinical trials, and regulatory approval.
The biologically active component in a drug formulation that produces the desired therapeutic effect, also known as the “drug substance.”
The specific composition and preparation of a pharmaceutical product, determining its physical form, dosage, and method of administration.
Medications derived from living organisms, such as proteins, antibodies, or nucleic acids, offering innovative therapeutic approaches.
A pharmaceutical product that is bioequivalent to a brand-name drug in terms of active ingredients, dosage form, strength, and route of administration, often available at a lower cost.
The study of how the body absorbs, distributes, metabolizes, and excretes drugs, influencing the drug’s concentration and effect over time.
The study of how drugs exert their effects on the body, including the mechanisms of action and the relationship between drug concentration and response.
An inactive substance given to patients in clinical trials as a control, helping researchers assess the true effects of a drug by comparing them to the effects of an inert substance.
A pharmaceutical product developed to treat rare medical conditions, often qualifying for special incentives and regulatory considerations.